Michelle Capobianco
CEO
Michelle Capobianco is the chief executive officer of Pancreatic Cancer North America, advocating for improved detection and treatment options for pancreatic cancer, highlighting the need for significant advancements beyond temporary solutions like daraxonrasib.
Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
31,487
Power
1,408$
Sentiment
6.00
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Canada | 1 | 6.00 | 0.08% | +0% | 38,005,238 | 31,487 | $1,700,000 | 1,408$ |
| Totals | 1 | 38,005,238 | 31,487 | $1,700,000 | 1,408$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Canada:
Michelle Capobianco, CEO of Pancreatic Cancer North America, emphasized the need for early detection.
6
Andre Bourbeau
George Zogopoulos
Jennifer Knox
Mark Johnson
Dana Johnson
Daniel Renouf
Connor Page
Jen Lovrics
The Globe and Mail: Drug that could extend lives of Canadians with pancreatic cancer remains out of reach for patients